Top Biotech Companies in Singapore (113)
WonderLab is a non-profit organization providing pediatric physical, occupational, and speech therapy services.
Nutrition Technologies (“NT”) researches, manufactures and supplies sustainable agricultural inputs (animal feed ingredients, biofertilisers and biological agents). NT uses its unique proprietary biotechnology and Black Soldier Fly Larvae (BSFL) rearing process to recycle nutrients from agricultural and food processing by-products. Their insect-based products help feed the growing agriculture and feed industries around the world. These products are suitable for application...
Syngenta Group is a leading global agricultural technology (AgTech) company headquartered in Basel, Switzerland. With over 50,000 employees across more than 90 countries, it provides farmers with innovative technology and expertise to increase productivity and ensure the growth of healthy, affordable, and sustainable food. The company is a world market leader in sustainable agriculture, offering a diverse portfolio of seeds...
Biomatch specializes in connecting top talent with leading companies in the life sciences sector, including pharmaceuticals, biotechnology, and medical technology. They offer tailored recruitment solutions, conduct candidate assessments, and aim to find the right job match for candidates and experts for companies.
TW Metals is a global specialty-metals distributor that stocks and processes tubing, pipe, bar, rod, wire, plate, coil, sheet, aerospace extrusions and related products. Its materials include stainless steel, aluminum, nickel, titanium and carbon alloys. The company operates an international distribution network, offers processing services such as cutting, and supplies specialty metal products to aerospace and commercial customers worldwide, supporting...
Axcynsis Therapeutics is at the forefront of developing cutting-edge Antibody Drug Conjugate (ADC) therapies. Our team's profound expertise, pioneering and proprietary ADC technology platform, enduring IP and know-how, substantial market opportunities, and strategic and effective execution position us as industry leaders in innovative cancer treatment solutions. At Axcynsis, our groundbreaking Matrix Optimization Platform is the cornerstone of our research and...
Heilind Electronics is a global electronic components distributor specializing in interconnect, electromechanical, and sensor solutions. Founded in 1974, the company is recognized as a leading distributor of connectors and terminal blocks, particularly in North America. They provide access to an extensive inventory from over 170 world-class manufacturers, offering products such as relays, switches, and thermal management solutions with a customer-first...
Professional Plastics, Inc. is a family-owned global leader in the fabrication and distribution of high-performance plastics, including sheets, rods, tubing, film, and parts. Founded in 1984, the company provides a vast inventory of engineering plastics, composites, and technical ceramics. They offer value-added fabrication services like precision CNC machining and serve over 200 industries through locations in the USA, Singapore, and...
Qritive makes cancer diagnosis fast, cheap, and accurate. Qritive develops AI-powered solutions that enable histopathologic diagnosisof cancer at scale. Our clinical-decision support system for pathologists unlocks efficiency and quality gain in diagnosis, which results in better patient outcome. It includes AI Modules, an Image Management System platform (Pantheon), and a network of pathologists on-demand for services (annotations, 2nd opinion...) Our digital...
Livestock disease prevention and sustainable agri productivity. Singaporean synbio startup funded by EF Venture Capital.
Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, "Novotech" and "PPC". Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services.
JCB is one of the world's largest privately owned manufacturers of construction and agricultural equipment, founded in 1945 by Joseph Cyril Bamford in Uttoxeter, England. Now the world's third-largest heavy equipment manufacturer, it produces more than 300 products — including backhoe loaders, excavators, telehandlers, skid steer loaders and Fastrac tractors — serving construction, agricultural, compaction, industrial, waste & recycling, and...
We’re TD SYNNEX (NYSE: SNX), a leading distributor and solutions aggregator for the IT ecosystem. We’re 22,000 of the IT industry’s best and brightest, who share an unwavering passion for bringing compelling technology products, services and solutions to the world. We’re an innovative partner that helps our customers maximize the value of IT investments, demonstrate business outcomes and unlock growth opportunities. At...
TD SYNNEX's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent channel analysts and repeated vendor awards place the company at or near the top globally, with 2024 gross billings around $80B and leadership versus Ingram Micro and Arrow. Global reach across 100+ countries and extensive vendor relationships underscores durable ecosystem influence.
Strong Revenue Growth: Recent quarters show revenue up 9.7% year over year in Q4 FY2025 and full-year FY2025 up roughly 6.9%, with non‑GAAP gross billings up 14.7% and records set for billings and earnings. Near‑term guidance for Q1 FY2026 indicates continued year‑over‑year growth if executed.
Healthy Cash Flow: Q4 FY2025 generated about $1.4B in free cash flow alongside strong operating cash flow. The company raised its dividend and continued buybacks, reflecting increased cash returns as performance accelerated late in FY2025.
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery...
Umami Bioworks is a marine biotechnology company developing cultivated seafood and other marine-derived biosolutions. Its AI-driven ALKEMYST platform combines genomics, stem cell biology, machine learning, and automation to enable scalable, traceable, cruelty-free production. The company licenses modular systems to manufacturing partners and supports applications in seafood, cosmetics, and nutrition, aiming to reduce overfishing and ecosystem strain while improving sustainable food...
Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed...
Sumitomo Electric Industries, Ltd. is a global technology and manufacturing company founded in Osaka in 1897. Its diversified business spans energy and environment, infocommunications, automotive, electronics, and industrial materials. The company supports people’s daily lives and industries through these five segments, serving customers worldwide via a network of around 400 group companies in 40 countries and a workforce exceeding 280,000...
Kemin Industries is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human health, food safety and protection of the global food supply chain. Kemin ingredients offer solutions across various industries including animal health, nutraceuticals,...
Rakuten Medical, Inc. is a global clinical stage biotechnology company developing and commercializing precision, cell-targeting investigational therapies on its AlluminoxTM platform, which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Outside of Japan, Alluminox therapies have not yet been approved as safe or effective by any regulatory authority. The company’s first drug...
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions....
Indegene's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyst assessments place the company in leadership cohorts for life sciences commercial AI/analytics and digital services for commercial operations, indicating defensible positioning in its specialization. The company is also described as a best-fit provider for digital commercialization, omnichannel activation, content operations at scale, and AI-driven commercial analytics, reinforcing category leadership within that lane.
Strong Revenue Growth: Revenue shows clear acceleration into FY26, including a strong year-over-year increase in the latest reported quarter and a positive exit rate from prior quarters as deal wins converted. Full-year FY25 results also show year-over-year growth alongside continued profitability, supporting an upward growth trajectory.
Product Line Growth: Capability expansion is evidenced by recent acquisitions intended to deepen data-driven omnichannel, media offerings, and consulting/transformation coverage, broadening the commercialization toolkit. Ongoing scaling post-IPO is also framed as broadening capabilities beyond prior scope within its core focus areas.
































